Skip to content

DEKA MEDIC: what changed

BE 0871.693.369NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€208,980
2024 · €189,722+€19,257
Equity
€151,483
2024 · €147,504+€3,980
Cash
€185,909
2024 · €123,387+€62,521
Balance sheet total
€402,506
2024 · €468,526-€66,019

Largest movements

2024 to 2025
Assets
  • Current investments -€120,603

    down €120,603 (-62.5%), from €193,103 to €72,500

  • Cash +€62,521

    up €62,521 (+50.7%), from €123,387 to €185,909

    mainly Net result for the year (+€208,980) and Current investments (+€120,603)

  • Deferred charges and accrued income -€6,189

    down €6,189 (-8.6%), from €71,888 to €65,699

Equity and liabilities
  • Other debts -€59,180

    down €59,180 (-19.7%), from €300,200 to €241,019

  • Accrued charges and deferred income -€17,600

    no longer reported in 2025; in 2024 it stood at €17,600

  • Tax, wage and social debts +€7,166

    up €7,166 (+348%), from €2,061 to €9,227

    of which Taxes: +€3,776

Income statement
  • Financial income +€30,092

    up €30,092 (+5,043%), from €597 to €30,689

  • Gross operating margin -€13,812

    down €13,812 (-5.3%), from €261,058 to €247,246

  • Depreciation -€8,084

    down €8,084 (-73.8%), from €10,948 to €2,864

  • Taxes +€5,136

    up €5,136 (+8.6%), from €59,616 to €64,752

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €189,722
Gross operating margin -€13,812
Depreciation +€8,084
Other operating charges +€80
Financial income +€30,092
Financial charges -€51
Taxes -€5,136
Result 2025 €208,980
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€150,659
Investment +€116,862
Financing -€205,000
Cash 2024 €123,387
Net result for the year +€208,980
Depreciation +€2,864
Receivables within one year +€2,625
Deferred charges and accrued income +€6,189
Trade debts -€385
Tax, wage and social debts +€7,166
Other debts -€59,180
Accrued charges and deferred income -€17,600
Investment in fixed assets (net) -€3,741
Current investments +€120,603
Contributions, distributions and other -€205,000
Cash 2025 €185,909
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €468,526 €402,506 -€66,019 -14.1%
Fixed assets 21/28 €77,522 €78,399 +€877 +1.1%
Tangible fixed assets 22/27 €4,047 €3,474 -€573 -14.2%
Plant, machinery and equipment 23 €4,019 €3,474 -€545 -13.6%
Furniture and vehicles 24 €28 - -€28
Financial fixed assets 28 €73,474 €74,924 +€1,450 +2.0%
Current assets 29/58 €391,004 €324,108 -€66,896 -17.1%
Amounts receivable within one year 40/41 €2,625 - -€2,625
Trade receivables 40 €2,150 - -€2,150
Other amounts receivable 41 €475 - -€475
Current investments 50/53 €193,103 €72,500 -€120,603 -62.5%
Cash at bank and in hand 54/58 €123,387 €185,909 +€62,521 +50.7%
Deferred charges and accrued income 490/1 €71,888 €65,699 -€6,189 -8.6%
Total equity and liabilities 10/49 €468,526 €402,506 -€66,019 -14.1%
Equity 10/15 €147,504 €151,483 +€3,980 +2.7%
Contributions 10/11 €52,400 €52,400 = 0.0%
Reserves 13 €68,860 €68,860 = 0.0%
Non-distributable reserves 130/1 €5,860 €5,860 = 0.0%
Reserves not available under the articles 1311 €5,860 €5,860 = 0.0%
Distributable reserves 133 €63,000 €63,000 = 0.0%
Profit (loss) carried forward 14 €26,244 €30,223 +€3,980 +15.2%
Amounts payable 17/49 €321,022 €251,023 -€69,999 -21.8%
Amounts payable within one year 42/48 €303,422 €251,023 -€52,399 -17.3%
Trade debts 44 €1,161 €777 -€385 -33.1%
Suppliers 440/4 €1,161 €777 -€385 -33.1%
Taxes, remuneration and social security 45 €2,061 €9,227 +€7,166 +348%
Taxes 450/3 - €3,776 +€3,776
Remuneration and social security 454/9 €2,061 €5,451 +€3,390 +164%
Other amounts payable 47/48 €300,200 €241,019 -€59,180 -19.7%
Accrued charges and deferred income 492/3 €17,600 - -€17,600
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €10,948 €2,864 -€8,084 -73.8%
Other operating charges 640/8 €1,086 €1,005 -€80 -7.4%
Gross operating margin 9900 €261,058 €247,246 -€13,812 -5.3%
Operating profit (loss) 9901 €249,024 €243,376 -€5,647 -2.3%
Financial income 75/76B €597 €30,689 +€30,092 +5,043%
Recurring financial income 75 €597 €30,689 +€30,092 +5,043%
Financial charges 65/66B €282 €334 +€51 +18.2%
Recurring financial charges 65 €282 €334 +€51 +18.2%
Profit (loss) for the period before taxes 9903 €249,338 €273,732 +€24,394 +9.8%
Income taxes 67/77 €59,616 €64,752 +€5,136 +8.6%
Profit (loss) for the period 9904 €189,722 €208,980 +€19,257 +10.2%
Profit (loss) for the period to be appropriated 9905 €189,722 €208,980 +€19,257 +10.2%

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€754,495 to €1.0m

Midpoint €867,621 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €151,483
Capitalised earnings €1.4m to €1.9m
Indication €754,495 to €1.0m

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€151,483
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€151,483

Capitalised earnings

net result for the year (9904)
2025
€208,980
2024
€189,722
2023
€171,451
2022
€184,924
2021
€144,273
Average result
€190,051
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.4m / €1.6m / €1.9m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.